Search results
Results from the WOW.Com Content Network
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. [4]
St. Jude Medical was founded in 1976 to further develop bi-leaflet artificial heart valves, which were originally created in 1972 at the University of Minnesota. [4] [5] St. Jude Medical's bi-leaflet valve was developed in large part by Dr. Demetre Nicoloff of the University of Minnesota and St. Jude Medical employee Don Hanson.
In January 2016, the company acquired On-X Life Technologies and its principal product, a mechanical heart valve called the On-X aortic valve replacement, for $130 million. [ 10 ] In October 2017, Artivion acquired JOTEC AG, a German-based developer of medical devices for aortic and peripheral vascular diseases, for €225 million. [ 11 ]
This page was last edited on 16 February 2024, at 22:49 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
The Hancock Aortic Tissue Valve was invented by Warren Hancock. [4] In the late 1960s and early 1970s, Warren Hancock, an American engineer, collaborated with the medical community to develop a cutting-edge bioprosthetic heart valve. The valve was first introduced by the American company Medtronic. [1]
The Department of Government Efficiency, or DOGE, headed by billionaires Elon Musk and Vivek Ramaswamy, says it is hiring "a very small number" of full-time, salaried positions.
CPI was a CRM company that revolutionized the pacemaker industry by introducing a long life lithium iodine pacemaker, a technology still utilized by a majority of the market. [ 3 ] In 1976, he founded St. Jude Medical where his team engineered the first bileaflet mechanical heart valve, which reduced the frequency of blood clots in patients.
Sankey was against such an eight-team model, describing the decreasing number of at-large selections from the four-team playoff as “counter-intuitive” to expansion. While he and Swarbrick ...